AAPL349.51+17.61 (+5.31%) ▲|ABBV294.83+8.83 (+3.09%) ▲|ABT115.51+6.11 (+5.59%) ▲|ACN264.27+9.71 (+3.81%) ▲|ADBE248.48+2.34 (+0.95%) ▲|AMAT369.40-12.52 (-3.28%) ▼|AMD488.78+4.88 (+1.01%) ▲|AMGN478.48+17.22 (+3.73%) ▲|AMT194.86+7.57 (+4.04%) ▲|AMZN266.03+15.34 (+6.12%) ▲|AVGO325.48-6.65 (-2.00%) ▼|AXP332.59+7.09 (+2.18%) ▲|BA177.00+3.69 (+2.13%) ▲|BAC51.63+1.97 (+3.97%) ▲|BKNG170.97+15.30 (+9.83%) ▲|BLK1,224.37+63.05 (+5.43%) ▲|BMY64.19+2.48 (+4.02%) ▲|BNY152.72+3.41 (+2.28%) ▲|BRK-B579.09+22.02 (+3.95%) ▲|C124.74+2.03 (+1.65%) ▲|CAT591.30-32.64 (-5.23%) ▼|CL98.76+3.14 (+3.28%) ▲|CMCSA24.85+1.18 (+4.99%) ▲|COF206.31-2.40 (-1.15%) ▼|COP136.94-7.46 (-5.17%) ▼|COST1,046.47+27.21 (+2.67%) ▲|CRM227.11+4.91 (+2.21%) ▲|CSCO103.61+0.64 (+0.62%) ▲|CVS79.96-11.45 (-12.53%) ▼|CVX216.96-8.31 (-3.69%) ▼|DE676.50+10.67 (+1.60%) ▲|DHR234.93+4.82 (+2.09%) ▲|DIS118.95+4.77 (+4.18%) ▲|DUK129.59+3.08 (+2.43%) ▲|EMR170.44+4.05 (+2.43%) ▲|FDX329.40+11.38 (+3.58%) ▲|GD364.87-9.63 (-2.57%) ▼|GE329.45+8.78 (+2.74%) ▲|GEV832.83-85.37 (-9.30%) ▼|GILD174.48+7.01 (+4.19%) ▲|GM92.43+4.09 (+4.63%) ▲|GOOG287.30+9.03 (+3.25%) ▲|GOOGL288.93+8.90 (+3.18%) ▲|GS928.00+31.91 (+3.56%) ▲|HD355.44+21.78 (+6.53%) ▲|HON228.47+4.42 (+1.97%) ▲|IBM254.32+4.28 (+1.71%) ▲|INTC58.27-2.28 (-3.77%) ▼|INTU356.64+11.92 (+3.46%) ▲|ISRG482.10+41.35 (+9.38%) ▲|JNJ276.32+10.15 (+3.81%) ▲|JPM352.11+14.13 (+4.18%) ▲|KO95.80+1.00 (+1.05%) ▲|LIN524.74+13.19 (+2.58%) ▲|LLY1,417.99+8.61 (+0.61%) ▲|LMT595.04-43.96 (-6.88%) ▼|LOW229.38+16.00 (+7.50%) ▲|LRCX221.43-9.29 (-4.03%) ▼|MA672.68+25.50 (+3.94%) ▲|MCD280.22+17.18 (+6.53%) ▲|MDLZ67.38+2.26 (+3.47%) ▲|MDT104.96+6.08 (+6.15%) ▲|META630.00+8.97 (+1.44%) ▲|MMM193.95+16.90 (+9.55%) ▲|MO78.01+1.07 (+1.39%) ▲|MRK150.36+5.69 (+3.93%) ▲|MS193.97+7.88 (+4.23%) ▲|MSFT555.80+34.81 (+6.68%) ▲|MU795.23-59.87 (-7.00%) ▼|NEE88.45+4.12 (+4.89%) ▲|NFLX66.39+2.97 (+4.68%) ▲|NKE40.49+2.01 (+5.22%) ▲|NOW108.81-0.35 (-0.32%) ▼|NVDA200.13-6.56 (-3.17%) ▼|ORCL123.73-2.46 (-1.95%) ▼|PEP142.42+5.15 (+3.75%) ▲|PFE30.79+0.79 (+2.63%) ▲|PG167.32+5.26 (+3.25%) ▲|PLTR171.70-3.70 (-2.11%) ▼|PM211.28+3.25 (+1.56%) ▲|QCOM173.19+8.76 (+5.33%) ▲|RTX198.43-5.39 (-2.64%) ▼|SBUX109.70+4.93 (+4.71%) ▲|SCHW93.37+4.09 (+4.58%) ▲|SO93.12-0.63 (-0.67%) ▼|SPG228.50+6.42 (+2.89%) ▲|T21.83+0.44 (+2.06%) ▲|TMO706.16+7.82 (+1.12%) ▲|TMUS159.17+4.76 (+3.08%) ▲|TSLA385.19-13.31 (-3.34%) ▼|TXN311.49-1.00 (-0.32%) ▼|UBER69.87+3.27 (+4.91%) ▲|UNH409.38+4.94 (+1.22%) ▲|UNP308.53+5.10 (+1.68%) ▲|UPS114.31+5.14 (+4.71%) ▲|USB61.03+1.14 (+1.90%) ▲|V436.57+16.15 (+3.84%) ▲|VZ46.17+0.93 (+2.06%) ▲|WFC87.43+1.90 (+2.22%) ▲|WMT129.17+4.31 (+3.45%) ▲|XOM169.27-8.19 (-4.62%) ▼|AAPL349.51+17.61 (+5.31%) ▲|ABBV294.83+8.83 (+3.09%) ▲|ABT115.51+6.11 (+5.59%) ▲|ACN264.27+9.71 (+3.81%) ▲|ADBE248.48+2.34 (+0.95%) ▲|AMAT369.40-12.52 (-3.28%) ▼|AMD488.78+4.88 (+1.01%) ▲|AMGN478.48+17.22 (+3.73%) ▲|AMT194.86+7.57 (+4.04%) ▲|AMZN266.03+15.34 (+6.12%) ▲|AVGO325.48-6.65 (-2.00%) ▼|AXP332.59+7.09 (+2.18%) ▲|BA177.00+3.69 (+2.13%) ▲|BAC51.63+1.97 (+3.97%) ▲|BKNG170.97+15.30 (+9.83%) ▲|BLK1,224.37+63.05 (+5.43%) ▲|BMY64.19+2.48 (+4.02%) ▲|BNY152.72+3.41 (+2.28%) ▲|BRK-B579.09+22.02 (+3.95%) ▲|C124.74+2.03 (+1.65%) ▲|CAT591.30-32.64 (-5.23%) ▼|CL98.76+3.14 (+3.28%) ▲|CMCSA24.85+1.18 (+4.99%) ▲|COF206.31-2.40 (-1.15%) ▼|COP136.94-7.46 (-5.17%) ▼|COST1,046.47+27.21 (+2.67%) ▲|CRM227.11+4.91 (+2.21%) ▲|CSCO103.61+0.64 (+0.62%) ▲|CVS79.96-11.45 (-12.53%) ▼|CVX216.96-8.31 (-3.69%) ▼|DE676.50+10.67 (+1.60%) ▲|DHR234.93+4.82 (+2.09%) ▲|DIS118.95+4.77 (+4.18%) ▲|DUK129.59+3.08 (+2.43%) ▲|EMR170.44+4.05 (+2.43%) ▲|FDX329.40+11.38 (+3.58%) ▲|GD364.87-9.63 (-2.57%) ▼|GE329.45+8.78 (+2.74%) ▲|GEV832.83-85.37 (-9.30%) ▼|GILD174.48+7.01 (+4.19%) ▲|GM92.43+4.09 (+4.63%) ▲|GOOG287.30+9.03 (+3.25%) ▲|GOOGL288.93+8.90 (+3.18%) ▲|GS928.00+31.91 (+3.56%) ▲|HD355.44+21.78 (+6.53%) ▲|HON228.47+4.42 (+1.97%) ▲|IBM254.32+4.28 (+1.71%) ▲|INTC58.27-2.28 (-3.77%) ▼|INTU356.64+11.92 (+3.46%) ▲|ISRG482.10+41.35 (+9.38%) ▲|JNJ276.32+10.15 (+3.81%) ▲|JPM352.11+14.13 (+4.18%) ▲|KO95.80+1.00 (+1.05%) ▲|LIN524.74+13.19 (+2.58%) ▲|LLY1,417.99+8.61 (+0.61%) ▲|LMT595.04-43.96 (-6.88%) ▼|LOW229.38+16.00 (+7.50%) ▲|LRCX221.43-9.29 (-4.03%) ▼|MA672.68+25.50 (+3.94%) ▲|MCD280.22+17.18 (+6.53%) ▲|MDLZ67.38+2.26 (+3.47%) ▲|MDT104.96+6.08 (+6.15%) ▲|META630.00+8.97 (+1.44%) ▲|MMM193.95+16.90 (+9.55%) ▲|MO78.01+1.07 (+1.39%) ▲|MRK150.36+5.69 (+3.93%) ▲|MS193.97+7.88 (+4.23%) ▲|MSFT555.80+34.81 (+6.68%) ▲|MU795.23-59.87 (-7.00%) ▼|NEE88.45+4.12 (+4.89%) ▲|NFLX66.39+2.97 (+4.68%) ▲|NKE40.49+2.01 (+5.22%) ▲|NOW108.81-0.35 (-0.32%) ▼|NVDA200.13-6.56 (-3.17%) ▼|ORCL123.73-2.46 (-1.95%) ▼|PEP142.42+5.15 (+3.75%) ▲|PFE30.79+0.79 (+2.63%) ▲|PG167.32+5.26 (+3.25%) ▲|PLTR171.70-3.70 (-2.11%) ▼|PM211.28+3.25 (+1.56%) ▲|QCOM173.19+8.76 (+5.33%) ▲|RTX198.43-5.39 (-2.64%) ▼|SBUX109.70+4.93 (+4.71%) ▲|SCHW93.37+4.09 (+4.58%) ▲|SO93.12-0.63 (-0.67%) ▼|SPG228.50+6.42 (+2.89%) ▲|T21.83+0.44 (+2.06%) ▲|TMO706.16+7.82 (+1.12%) ▲|TMUS159.17+4.76 (+3.08%) ▲|TSLA385.19-13.31 (-3.34%) ▼|TXN311.49-1.00 (-0.32%) ▼|UBER69.87+3.27 (+4.91%) ▲|UNH409.38+4.94 (+1.22%) ▲|UNP308.53+5.10 (+1.68%) ▲|UPS114.31+5.14 (+4.71%) ▲|USB61.03+1.14 (+1.90%) ▲|V436.57+16.15 (+3.84%) ▲|VZ46.17+0.93 (+2.06%) ▲|WFC87.43+1.90 (+2.22%) ▲|WMT129.17+4.31 (+3.45%) ▲|XOM169.27-8.19 (-4.62%) ▼|
17.4 C
New York
Thursday, November 5, 2026

Tag: Regulatory

newsFORsourcecompanycontentinformationreleases1market

Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligence

The 2025 Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects that advance health and sustainability through cooperation between researchers from...

Challenge accepted: New funding for ambitious projects within biomanufacturing, cardiometabolic diseases, and artificial intelligence

The 2025 Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects that advance health and sustainability through cooperation between researchers from...

Continuation of the customs adjustment process initiated by the Tax Authority

BOGOTA, Colombia, June 26, 2025 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC, the "Company" or "Ecopetrol" and together with its subsidiaries, the "Ecopetrol...

BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages...

NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Bausch + Lomb Corporation (“Bausch & Lomb” or the “Company”) (NYSE:BLCO) on behalf of Bausch & Lomb stockholders. Our investigation concerns whether Bausch & Lomb has violated the federal securities laws and/or engaged in other unlawful business practices.

FIDDLEHEAD RESOURCES ANNOUNCES AMENDED CREDIT AGREEMENT, FERRIER ADJUSTED PURCHASE PRICE REDUCTION AND CYNTHIA ACQUISITION UPDATE

CALGARY, AB, June 26, 2025 /CNW/ - Fiddlehead Resources Corp. ("Fiddlehead" or the "Company") (TSXV: FHR), is pleased to announce the amendment and extension...

Bitcoin Treasury Corporation Announces the Resumption of Trading of Its Common Shares on the TSX Venture Exchange, Closing of Common Share Offering and Initial...

Trading to Commence Under Symbol “BTCT”

PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PepGen To Contact Him Directly To Discuss...

ANDLAUER HEALTHCARE GROUP PROVIDES UPDATE ON APPROVALS FOR SALE TO UPS

TORONTO, June 26, 2025 /CNW/ - Andlauer Healthcare Group Inc. (TSX: AND) ("AHG" or the "Company") today announced that the Ontario Superior Court of Justice...

Tempus AI, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. December 16, 2024 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses

Pendopharm® and KalVista® Partner to Bring First Oral On-Demand HAE Treatment to Canada

MONTREAL, June 26, 2025 /CNW/ - Pendopharm®, a division of Pharmascience Inc., has entered into an exclusive distribution agreement with KalVista Pharmaceuticals, Inc. (NASDAQ:...

Extendicare Announces Renewal of Normal Course Issuer Bid

MARKHAM, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under the terms of the NCIB, the Company may purchase for cancellation up to 7,281,193 of its common shares (the “Common Shares”), representing 10% of its public float of issued and outstanding Common Shares. As at June 20, 2025, there were 83,817,909 Common Shares issued and outstanding and the public float was 72,811,939 Common Shares, calculated in accordance with the rules of the TSX.

Anti-CCR8 Antibodies Market to Witness Remarkable Growth Trajectory During the Forecast Period (2025-2040) Across 7MM | DelveInsight

The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The anti-CCR8 inhibitor market is expected to witness substantial...

Anti-CCR8 Antibodies Market to Witness Remarkable Growth Trajectory During the Forecast Period (2025-2040) Across 7MM | DelveInsight

The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The anti-CCR8 inhibitor market is expected to witness substantial...

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET

GetGo will operate as a separate, stand-alone business unit, maintain myPerks loyalty program; 35 stores to be divested in accordance with regulatory requirements LAVAL, QC and...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRegulatory

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers